Best Grants for Cancer Nonprofits in Nevada

The Mathers Charitable Foundation Grant focuses on advancing basic scientific research with the potential to transform human health. It supports institutions and investigators in fields such as immunology, cancer biology, and neuroscience while prioritizing impactful, foundational discoveries. The foundation empowers researchers to drive innovative solutions and foster meaningful contributions to science and society. Eligibility includes U.S.-based institutions and principal investigators with equipped labs, while ineligible entities include overseas institutions and private foundations.

Underinsured patients being treated for amyloidosis in Nevada can receive help covering prescription drug copays and Medicare Part B premiums through this HealthWell Foundation fund, with awards up to US $8,000. Cancer and oncology nonprofits assisting such patients may help them apply if they meet medical, insurance, and income guidelines and receive treatment in the U.S.

Nonprofit, tax-exempt 501(c)(3) educational or research institutions in Nevada conducting childhood cancer research using non-animal methods can apply for the Alternatives in Research (AiR) Challenge program, with awards of US $210,000. With a mission to advance alternatives to animal-based science, Alternatives Research & Development Foundation supports non-clinical and pre-clinical projects improving knowledge or treatment of childhood cancers.

Professional elderly blues musicians facing medical or basic living emergencies can receive US $500 in assistance for healthcare, transportation, utilities, or burial costs. While national in scope, this support from Pinetop Perkins Foundation may benefit Nevada artists dealing with cancer or other serious health conditions who meet the income and age requirements.

Nonprofit and other eligible U.S. organizations conducting patient-centered cancer research in Nevada and beyond can apply for up to US $13,000,000 to study comparative clinical effectiveness across the cancer care continuum. With a mission to improve healthcare decisions, Patient-Centered Outcomes Research Institute supports projects on screening barriers, evidence-based treatment, and survivorship care needs.

Researchers leading cancer/oncology projects to improve cancer outcomes in U.S. communities, including Nevada, can apply for pilot funding up to US $50,000 to test innovative, evidence-based strategies. Focus areas include prevention, early detection, treatment, and survivorship, especially for populations facing higher cancer burdens or economic hardship, through Indiana Clinical and Translational Sciences Institute.

Nevada cancer and oncology research organizations can access funding through the Patient-Centered Outcomes Research Institute for retrospective observational comparative effectiveness studies using existing data sources. Eligible private and public sector entities, including IRS-recognized U.S. organizations, may request up to US $2,000,000 to generate patient-centered evidence that improves health decision making and outcomes in cancer and related conditions.

Academic and research institutions conducting translational cancer research in Nevada and other eligible U.S. locations can seek funding to improve cancer prevention, early detection, diagnosis, and treatment. National Institutes of Health SPORE P50 center grants provide US $25,000,000 for organ-specific or biologically related human cancer studies that aim for a clear translational endpoint within the grant period.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support through this scholarship; funds may be used for school, certifications, or conferences. Cancer-focused organizations in Nevada may know eligible individuals to refer to the Heart of Illinois Community Foundation program.

Full-time radiation oncology faculty clinicians conducting cancer research in Nevada can apply for the ASTRO-ACS Clinician Scientist Development Grant, receiving US $135,000 per year for 3–5 years to build independent research careers. Focused on cancer and radiation oncology, this American Society for Radiation Oncology and American Cancer Society partnership supports clinician scientists at U.S. academic or eligible nonprofit institutions.

Practicing radiation oncologists in Nevada conducting cancer research can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years for research across the cancer continuum. This American Society for Radiation Oncology partnership supports clinician-scientists advancing cancer/oncology care and outcomes.

Nevada cancer and healthcare organizations can access funding through Incyte for programs that provide healthcare information to students, providers, patients, caregivers, and advocates. Eligible applicants include medical schools, associations, hospitals, patient advocacy groups, and certain 501(c)(3) nonprofits focused on cancer and other diseases, medical education, nursing, or patient care services.

Nevada cancer-focused nonprofits, hospitals, medical schools, and patient advocacy groups can seek support for healthcare education and information initiatives. Focused on improving the lives of patients with cancer and other diseases, Incyte invites eligible organizations to request charitable contributions, sponsorships, or memberships that expand access to healthcare information for students, providers, patients, and caregivers.

Cancer research institutions and oncology-focused organizations in Nevada and across North America can seek funding to study optimal combinations of radiation therapy and immunotherapy, with typical awards of US $50,000 - US $100,000. With a mission to advance cancer treatment, Radiation Oncology Institute supports projects on synergy mechanisms, toxicity reduction, education, and access to combined therapies.

The Radiation Oncology Institute (ROI) Innovation Awards, offered by the American Society for Radiation Oncology, aim to accelerate innovative ideas in radiation therapy. Currently accepting applications for the 2026 awards, the program focuses on optimizing the combination of radiation therapy and immunotherapy to enhance cancer treatment outcomes. By supporting practical research, ROI strives to transform clinical practices and improve patient care in the fight against cancer.

Pfizer is offering a grant opportunity for independent medical education initiatives focused on Muscle Invasive Bladder Cancer (MIBC). This program aims to address the current knowledge gaps among healthcare professionals regarding emerging treatment data and its potential impact on clinical practices. By collaborating with Astellas, Pfizer seeks proposals that enhance awareness and understanding of the evolving MIBC landscape, ultimately improving patient outcomes in this critical area of unmet medical need.

The Joyce Bytof Memorial Cancer Survivors Scholarship, established by Joyce Bytof in collaboration with the American Cancer Society, supports childhood cancer survivors graduating from specific Wisconsin high schools. This scholarship aims to assist them in pursuing higher education despite the financial and academic challenges posed by their experiences. Joyce's legacy continues to inspire hope and resilience among young survivors as they strive for academic success and a brighter future.

The AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant supports innovative research on upper gastrointestinal malignancies, which are responsible for over one million deaths globally in 2023. This grant encourages collaboration between U.S. and Asian institutions, focusing on resistance, metastasis, and novel treatment strategies. Proposals should detail plans for clinical translation and are open to researchers at all career stages, especially those new to upper GI cancer research.

Bristol Myers Squibb Foundation Inc supports independent medical education to enhance healthcare professional competence and improve patient health outcomes. Their mission is to be a global leader in innovative medical education, focusing on evidence-based activities that address critical gaps in knowledge. By fostering excellence in healthcare, they aim to ensure measurable improvements in performance and patient outcomes across various disease areas.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The American Heart Association is seeking proposals to study the prevalence and treatment of cardiovascular, kidney, and metabolic diseases among cancer patients and survivors. Given the over 16.7 million cancer survivors in the U.S., this research aims to highlight critical health disparities, identify treatment modalities, and explore shared risk factors. Applications focusing on underrepresented populations and utilizing real-world data sources are especially encouraged, aiming to improve health outcomes in this vulnerable group.

The ASCO Clinical Oncology & Research Experience (ASCO CORE) offers medical students immersive exposure to the field of oncology through shadowing experiences in clinical and research settings. With two distinct tracks, participants can gain insights into patient care or research practices, guided by mentors. Eligible students must be enrolled in a U.S. DO or MD program and maintain a good academic record. This program aims to inspire the next generation of oncology professionals.

Grants Program for Penn Investigators - Faculty Awards

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Faculty Awards

Faculty awards are for two years with a funding level up to $200,000 per year.

Grants Program for Penn Investigators - Early career awards for Fellows, Postdocs and Instructors

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Early career awards for Fellows, Postdocs and Instructors

Early career awards for Fellows, Postdocs and Instructors up to $100,000 for one year. Grants are eligible for competitive renewal upon reapplication and are contingent on progress the first year.

The NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08) aims to enhance the careers of clinical scientists committed to cancer research. This NIH-supported program provides protected time for research and encourages underrepresented individuals in health-related sciences. With deadlines spanning from 2025 to 2027, the program focuses on training and developing the skills necessary to compete for significant research funding and address health disparities in cancer research.

This initiative aims to support research interventions targeting disparities in liver diseases and liver cancer among underserved populations in the U.S. It encourages innovative approaches to reduce health inequities and improve health outcomes. The funding opportunity is available through various deadlines for both standard and renewal applications, promoting multi-level strategies to address these critical health issues effectively.

The National Cancer Institute (NCI) invites applications for the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) program. This funding opportunity focuses on advanced pre-clinical research aimed at developing nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards will support the maturation of innovative nanomedicines using nanoparticles and nano-devices, enhancing cancer treatment efficacy. Successful projects will progress towards further NCI translational programs, such as the NExT initiative.